Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion evidence source_evidence_literature NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion SIO_000772 17009404 NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion wasDerivedFrom lhgdn-20090331 NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_assertion wasGeneratedBy ECO_0000203 NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP105895.RAzlHjV-MoSBtxX23fU1JRCq5uZ97KYkMdW-HGn_SKrCg130_provenance.